Test Platform

The PromarkerD Laboratory Developed Test (LDT) and the In Vitro Diagnostic (IVD) Test are two versions of PromarkerD test system. These two tests utilise mass spectrometry or immunoassay technology to measure the concentration of the three protein biomarkers.


License & Partnership Opportunity

Proteomics International seeks partnership to commercialise the PromarkerD test.

If you are a testing laboratory equipped with mass spectrometers, IVD manufacturer, IVD distributor, or health professionals interested in using PromarkerD, please contact us for more information.

Laboratory Developed Test (LDT)

PromarkerD has been developed to be delivered by testing laboratories equipped with mass spectrometers.


In Vitro Diagnostic Test (IVD)

PromarkerD has been developed to be delivered via an enzyme linked immune-assay (ELISA) kit, also known as an in vitro diagnostic test (IVD) kit.

Complementary Diagnostic

PromarkerD is being developed to be used as a complementary diagnostic (CDx), assisting physician’s decision making when treating diabetes.